Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT04388475
Title Open-label Study Investigating of OKN-007 Combined With Temozolomide in Patients With Recurrent Glioblastoma
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Oblato, Inc.
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
University of Alabama at Birmingham Birmingham Alabama 35294 United States Details
St. Joseph's Hospital and Medical Center Phoenix Arizona 85013 United States Details
Providence Saint John's Health Center - John Wayne Cancer Institute Santa Monica California 90404 United States Details
Swedish Medical Center Englewood Colorado 80113 United States Details
AdventHealth Orlando Orlando Florida 32804 United States Details
University of Iowa Iowa City Iowa 52242 United States Details
Norton Healthcare Louisville Kentucky 40241 United States Details
Henry Ford Health System Detroit Michigan 48202 United States Details
Wake Forest Baptist Comprehensive Cancer Center Winston-Salem North Carolina 27157 United States Details
The University of Toledo Toledo Ohio 43606 United States Details
The University of Oklahoma Oklahoma City Oklahoma 73117 United States Details
Lifespan Office of Research Providence Rhode Island 02903 United States Details
St. Joseph Hospital of Orange Seattle Washington 35143 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field